In the context of cancer, it is possible that OM-MUC1 also acts by maturing M-MDSC (Ly6Chi), which are well known to suppress anti-tumor immune responses, although this possibility needs to be formally tested. This evidence concerns the gene MUC1 and ocular melanoma.